Insider Trading & SAST disclosures for Sanofi Consumer Healthcare
The latest disclosure under SEBI Prohibition of Insider Trading regulations was made by
Opal Bidco SAS in Sanofi Consumer Healthcare where Acquisition of 2,504,630
Equity Shares done at an average price of Rs. 4982.1
was reported to the exchange on June 13, 2025.
The latest disclosures under SEBI SAST(Substantial Acquisition of Shares and Takeovers) Regulations, 2011 transaction was made by
Nippon India Mutual Fund in Sanofi Consumer Healthcare where Acquisition of 30,000
shares done
was reported to the exchange on May 4, 2026.
Insider trades are disclosures under SEBI (Prohibition of Insider Trading) Regulations, 2015 ([Regulation 7 (2) with 6(2)] made by corporate insiders: promoters, officers, directors, employees and large shareholders who are buying and selling stock in their own companies.
| Client Name |
Client Category |
Action* |
Reported To/By Exchange |
Quantity |
Post Transaction Holding |
Traded % |
Avg. Price |
Value |
Period |
Regulation (Insider/SAST) |
Security Type |
Mode |
|
Nippon India Mutual Fund
|
Other |
Acquisition |
09 Jun 2026 |
30,000 |
1,162,073
(5.04%)
|
0.13%
|
|
-
|
14 Jun 2024
29 Apr 2026 |
SAST (29(1)) |
- |
Market |
|
Opal Bidco SAS
|
Promoter Group |
Acquisition |
13 Jun 2025 |
2,504,630 |
2,504,630
(10.87%)
|
10.88%
|
4982.1 |
12,478,191,892
|
11 Jun 2025
11 Jun 2025 |
Insider Trading |
Equity Shares |
Off Market |
|
Opal Bidco SAS
|
Promoter |
Acquisition |
03 Jul 2025 |
2,504,630 |
2,504,630
(10.87%)
|
10.87%
|
|
-
|
11 Jun 2025
11 Jun 2025 |
SAST (29(1)) |
- |
Open Offer |
|
Opella Healthcare Participations B.V.
|
Promoter |
Acquisition |
28 Oct 2024 |
4,865 |
13,909,587
(60.40%)
|
0.02%
|
4781.8 |
23,263,700
|
25 Oct 2024
25 Oct 2024 |
Insider Trading |
Equity Shares |
Inter-se Transfer |
|
Sanofi
|
Promoter |
Disposal |
28 Oct 2024 |
4,865 |
0
(0%)
|
0.02%
|
4781.8 |
23,263,700
|
25 Oct 2024
25 Oct 2024 |
Insider Trading |
Equity Shares |
Inter-se Transfer |
|
Sanofi
|
Promoter |
Disposal |
06 Nov 2024 |
4,865 |
-
|
0.02%
|
|
-
|
25 Oct 2024
25 Oct 2024 |
SAST (29(2)) |
- |
Inter-se Transfer |
|
Opella Healthcare Participations BV
|
Promoter |
Acquisition |
06 Nov 2024 |
4,865 |
13,909,587
(60.40%)
|
0.02%
|
|
-
|
25 Oct 2024
25 Oct 2024 |
SAST (29(2)) |
- |
Inter-se Transfer |
|
Opella Healthcare Participations BV
|
Other |
Acquisition |
06 Nov 2024 |
4,865 |
-
|
0.02%
|
|
-
|
10 Oct 2024
10 Oct 2024 |
SAST (10(6)) |
- |
- |
|
Opella Healthcare Participations B.V.
|
Promoter Group |
Acquisition |
14 Oct 2024 |
13,904,722 |
13,904,722
(60.37%)
|
60.37%
|
4982.0 |
69,274,020,240
|
10 Oct 2024
11 Oct 2024 |
Insider Trading |
Equity Shares |
Inter-se Transfer |
|
Hoechst GmbH
|
Promoter |
Disposal |
14 Oct 2024 |
13,904,722 |
0
(0%)
|
60.37%
|
4982.0 |
69,274,020,240
|
10 Oct 2024
11 Oct 2024 |
Insider Trading |
Equity Shares |
Inter-se Transfer |
|
Opella Healthcare Participations BV
|
Promoter |
Acquisition |
24 Oct 2024 |
13,904,722 |
13,904,722
(60.37%)
|
60.37%
|
|
-
|
10 Oct 2024
10 Oct 2024 |
SAST (29(1)) |
- |
Inter-se Transfer |
|
Hoechst GmbH
|
Promoter |
Disposal |
24 Oct 2024 |
13,904,722 |
-
|
60.37%
|
|
-
|
10 Oct 2024
10 Oct 2024 |
SAST (29(2)) |
- |
Inter-se Transfer |
|
Opella Healthcare Participations BV
|
Other |
Acquisition |
24 Oct 2024 |
13,904,722 |
-
|
60.37%
|
|
-
|
10 Oct 2024
10 Oct 2024 |
SAST (10(6)) |
- |
- |
|
Opella Healthcare Participations B V
|
Other |
Acquisition |
22 Oct 2024 |
13,909,587 |
-
|
60.40%
|
|
-
|
10 Oct 2024
10 Oct 2024 |
SAST (10(5)) |
- |
None |
|
Sanofi SA & PAC
|
Promoter |
Acquisition |
14 Oct 2024 |
13,909,587 |
13,909,587
(60.40%)
|
60.40%
|
|
-
|
17 Jun 2024
17 Jun 2024 |
SAST (29(1)) |
- |
Sch.of Arrangement |
*Actions covered:
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.